The SOTIO pipeline also includes two clinical-stage programs: BOXR1030, a metabolically-enhanced CAR-T cell therapy targeting GPC3-expressing tumors; and SOT201, a next-generation PD-1-targeting ...
In a statement, Ipsen said that GPC3 is a well-validated target in oncology and is highly expressed across several tumour types, including hepatocellular carcinoma (HCC). Meanwhile, MAIT cells are ...
The incidence of hepatocellular carcinoma (HCC) is increasing worldwide. Extracellular vesicles (EVs) contain sufficient bioactive substances and are carriers of intercellular information exchange, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback